Literature DB >> 25488055

Reference datasets for bioequivalence trials in a two-group parallel design.

Anders Fuglsang1, Helmut Schütz, Detlew Labes.   

Abstract

In order to help companies qualify and validate the software used to evaluate bioequivalence trials with two parallel treatment groups, this work aims to define datasets with known results. This paper puts a total 11 datasets into the public domain along with proposed consensus obtained via evaluations from six different software packages (R, SAS, WinNonlin, OpenOffice Calc, Kinetica, EquivTest). Insofar as possible, datasets were evaluated with and without the assumption of equal variances for the construction of a 90% confidence interval. Not all software packages provide functionality for the assumption of unequal variances (EquivTest, Kinetica), and not all packages can handle datasets with more than 1000 subjects per group (WinNonlin). Where results could be obtained across all packages, one showed questionable results when datasets contained unequal group sizes (Kinetica). A proposal is made for the results that should be used as validation targets.

Entities:  

Mesh:

Year:  2014        PMID: 25488055      PMCID: PMC4365103          DOI: 10.1208/s12248-014-9704-6

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  3 in total

1.  A practical approach for comparing means of two groups without equal variance assumption.

Authors:  Hansheng Wang; Shein-Chung Chow
Journal:  Stat Med       Date:  2002-10-30       Impact factor: 2.373

2.  Reference datasets for 2-treatment, 2-sequence, 2-period bioequivalence studies.

Authors:  Helmut Schütz; Detlew Labes; Anders Fuglsang
Journal:  AAPS J       Date:  2014-09-12       Impact factor: 4.009

3.  The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before and after food.

Authors:  D Clayton; A Leslie
Journal:  J Int Med Res       Date:  1981       Impact factor: 1.671

  3 in total
  2 in total

1.  On the Incorrect Statistical Calculations of the Kinetica Software Package in Imbalanced Designs.

Authors:  S Morales-Alcelay; J M de la Torre de Alvarado; A García-Arieta
Journal:  AAPS J       Date:  2015-03-19       Impact factor: 4.009

2.  Reference Datasets for Studies in a Replicate Design Intended for Average Bioequivalence with Expanding Limits.

Authors:  Helmut Schütz; Detlew Labes; Michael Tomashevskiy; Mario González-de la Parra; Anastasia Shitova; Anders Fuglsang
Journal:  AAPS J       Date:  2020-02-07       Impact factor: 4.009

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.